Related Experiment Video
Updated: Jun 15, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Prevalence and risk factors of suppurative complications in children with pneumonia
Patrice François1, Amélie Desrumaux, Christine Cans
1Quality of Care Unit, Centre Hospitalier Universitaire de Grenoble, Grenoble, France. pfrancois@chu-grenoble.fr
Insights
Ibuprofen use before hospitalization is linked to suppurative complications in children with community-acquired pneumonia. This finding highlights potential risks associated with non-steroidal anti-inflammatory drug use in pediatric pneumonia cases.
Area of Science:
- Pediatric infectious diseases
- Pulmonology
- Clinical pharmacology
Background:
- Community-acquired pneumonia (CAP) is a common childhood illness.
- Suppurative complications, such as empyema and lung abscess, can increase morbidity.
- Identifying risk factors for these complications is crucial for timely intervention.
Purpose of the Study:
- To determine baseline characteristics associated with suppurative complications in pediatric CAP.
- To investigate the role of prehospital treatments in the development of complicated pneumonia.
Main Methods:
- Retrospective study of 767 children (28 days to 15 years) with CAP treated between 1995 and 2003.
- Complicated pneumonia defined as the presence of empyema and/or lung abscess.
- Multivariable analysis to identify independent risk factors.
Main Results:
- Suppurative complications occurred in 90 children (11.7%), with a rising prevalence from 3% to 23% between 1995 and 2003.
- Children with complicated pneumonia were older and had a longer symptomatic period.
- Preadmission ibuprofen use was independently associated with complicated pneumonia (adjusted OR = 2.57).
Conclusions:
- Preadmission ibuprofen use is associated with an increased risk of suppurative complications in pediatric CAP.
- This association warrants further investigation and may inform clinical guidelines regarding NSAID use in children with pneumonia.
Aim:
To identify the baseline characteristics associated with suppurative complications in children with community-acquired primary pneumonia.
Methods:
A retrospective study included all children from 28 days to 15 years old, who presented with community-acquired pneumonia at two French hospitals from 1995 to 2003. Complicated pneumonia was defined by the presence of empyema and/or lung abscess.
Results:
Of 767 children with community-acquired pneumonia, 90 had suppurative complications: 83 cases of pleural empyema and seven cases of lung abscess. The mean prevalence of complicated pneumonia was 3% during the 1995-1998 period, and then steadily increased following a linear trend to reach 23% in 2003. Children with complicated pneumonia were older and had a longer symptomatic period preceding hospitalization. They were more likely to receive antibiotics, especially aminopenicillins (p < 0.01), and nonsteroidal anti-inflammatory drugs, especially ibuprofen (p < 0.001). In multivariable analysis, ibuprofen was the only preadmission therapy that was independently associated with complicated pneumonia [adjusted OR = 2.57 (1.51-4.35)].
Conclusion:
This study confirms an association between the use of prehospital ibuprofen and suppurative pneumonic complications.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: